البلد: الولايات المتحدة
اللغة: الإنجليزية
المصدر: NLM (National Library of Medicine)
RISPERIDONE (UNII: L6UH7ZF8HC) (RISPERIDONE - UNII:L6UH7ZF8HC)
Hikma Pharmaceutical
RISPERIDONE
RISPERIDONE .25 mg
ORAL
PRESCRIPTION DRUG
Adults Risperidone tablets, USP are indicated for the acute and maintenance treatment of schizophrenia [see Clinical Studies (14.1)]. Adolescents Due to Janssen Pharmaceuticals Corporation's marketing exclusivity rights, this drug product is not labeled for use in pediatric patients with schizophrenia. Pediatric use information for the treatment of pediatric patients with schizophrenia, 13 to 17 years of age, is approved for Janssen Pharmaceuticals Corporation's risperidone drug products. Monotherapy Adults and Pediatrics Risperidone tablets USP, are indicated for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in adults [see Clinical Studies (14.2)]. Due to Janssen Pharmaceuticals Corporation's marketing exclusivity rights, this drug product is not labeled for use in pediatric patients with bipolar mania. Pediatric use information for the treatment of pediatric patients with bipolar mania, 10 to 17 years of age, is approved for Janssen Pharmaceut
Risperidone Tablets, USP 0.25 mg dark yellow, oval-shape, film-coated tablets with beveled edges, engraved with W10 and supplied as: Bottles of 60 Tablets Bottles of 500 Tablets 0.5 mg red-brown, oval-shaped, film-coated tablets with beveled edges, engraved with W11 and supplied as: Bottles of 60 Tablets Bottles of 500 Tablets 1 mg white, oval-shaped, film-coated tablets with beveled edges, engraved with W12 and supplied as: Bottles of 60 Tablets Bottles of 500 Tablets 2 mg orange, oval-shaped, film-coated tablets, engraved with W13 and supplied as: Bottles of 60 Tablets Bottles of 500 Tablets 3 mg yellow, oval-shaped, film-coated tablets with beveled edges, engraved with W14 and supplied as: Bottles of 60 Tablets Bottles of 500 Tablets 4 mg green, modified capsule-shaped, film-coated tablets, engraved with W15 and supplied as: Bottles of 60 Tablets Bottles of 500 Tablets Storage and Handling Risperidone tablets, USP: Store at 20-25ºC (68-77ºF) [See USP Controlled Room Temperature]. Protect from light and moisture. Keep out of reach of children.
Abbreviated New Drug Application
RISPERIDONE- RISPERIDONE TABLET HIKMA PHARMACEUTICAL ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE RISPERIDONE SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR RISPERIDONE. RISPERIDONE TABLETS, USP INITIAL U.S. APPROVAL: 1993 WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS TREATED WITH ANTIPSYCHOTIC DRUGS ARE AT AN INCREASED RISK OF DEATH. RISPERIDONE IS NOT APPROVED FOR USE IN PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS. (5.1) RECENT MAJOR CHANGES Boxed Warning 08/2008 Warnings and Precautions (5.1) 08/2008 Warnings and Precaustion, Leukopenia, Neutropenia, and Agranulocytosis (5.8) 09/2009 INDICATIONS AND USAGE Risperidone is an atypical antipsychotic agent indicated for: Treatment of schizophrenia in adults and adolescents aged 13-17 years (1.1) Alone, or in combination with lithium or valproate, for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in adults, and alone in children and adolescents aged 10-17 years (1.2) _Due to Janssen Pharmaceuticals Corporation's marketing exclusivity rights, this drug product is not labeled for use in_ _pediatric patients with schizophrenia, bipolar mania or autistic disorder._ (1.1, 1.2, 1.3) DOSAGE AND ADMINISTRATION INITIAL DOSE T ITRATIO N TARGET DOSE EFFECTIVE DOSE RANGE Schizophrenia – adults (2.1) 2 mg/day 1-2 mg daily 4-8 mg daily 4-16 mg/day Bipolar mania –adults (2.2) 2-3 mg/day 1 mg daily 1-6 mg/day 1-6 mg/day DOSAGE FORMS AND STRENGTHS Tablets: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg (3) CONTRAINDICATIONS Known hypersensitivity to the product (4) WARNINGS AND PRECAUTIONS Cerebrovascular events, including stroke, in elderly patients with dementia-related psychosis. Risperidone is not approved for use in patients with dementia-related psychosis (5.2) Neuroleptic Malignant Syndrome (5.3) Tardive اقرأ الوثيقة كاملة